Corpuscles of stannius protein, stanniocalcin
AssigneeHuman Genomes Sciences, Inc.
InventorsHenrik S. Olsen, Mark D. Adams
Life of this patent
Estimating the term…
Abstract
The present invention relates to human Corpuscles of Stannius polypeptides and DNA (RNA) encoding such polypeptides. Also provided is a procedure for producing such polypeptides by recombinant techniques and antagonists against such polypeptides. Also provided are methods of using the polypeptide therapeutically for treating renal, bone and heart diseases and for using the antagonists for treating hypocalcemia and osteoporosis. Also provided is a diagnostic assay to detect mutations in the nucleic acid sequence encoding the polypeptide and for altered concentrations of the polypeptide in a sample derived from a host.
Claims16
An isolated polypeptide comprising a member selected from the group consisting of:
- (a) a polypeptide having an amino acid sequence according to amino acids 1 to 212 of SEQ ID NO:2;
- (b) a polypeptide which is a fragment of the amino acid sequence according to SEQ ID NO:2, wherein said fragment retains the calcium uptake inhibitory activity of the polypeptide according to SEQ ID NO:2;
- and
- (c) a polypeptide consisting of amino acid residues 1 to 20 of SEQ ID NO:2.
An isolated polypeptide comprising a member selected from the group consisting of:
- (a) a polypeptide encoded by the portion of the human cDNA of ATCC Deposit No. 75652 which encodes the mature polypeptide;
- (b) a polypeptide which is a fragment (a), wherein said fragment retains the calcium uptake inhibitory activity of the polypeptide of (a);
- and
- (c) a polypeptide consisting of the N-terminal 20 amino acids of the polypeptide encoded by the human cDNA of ATCC Deposit No. 75652.
Dependencies are inferred from the claim text.